Navigation Links
VIVUS Provides Qnexa Regulatory Update
Date:1/9/2012

mission of the Qnexa NDA.  The resubmission plan allowed VIVUS to seek approval for an initial indication that included obese men and women of non-childbearing potential which contained a contraindication for women of childbearing potential. Based on this agreement, VIVUS resubmitted the Qnexa NDA in October 2011.  The FDA accepted the NDA for review on November 3, 2011.The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA is scheduled to review the Qnexa NDA on February 22, 2012.  The target date for the FDA to complete its review of the Qnexa NDA is April 17, 2012.

About QnexaQnexa [kyoo-nek-suh] is an investigational drug candidate being developed to address weight loss, type 2 diabetes and obstructive sleep apnea.  Qnexa is a once-a-day, proprietary, oral, controlled-release formulation of low-dose phentermine and topiramate, which is designed to decrease appetite and increase satiety (the sense of feeling full), the two main mechanisms that impact eating behavior.  In phase 2 and 3 clinical data to date, patients taking Qnexa have demonstrated statistically significant weight loss, glycemic control, and improvement in cardiovascular risk factors, when used in combination with a diet and lifestyle modification program.

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health.  The company's lead investigational product in clinical development, Qnexa, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators.  VIVUS received a Complete Response Letter, or CRL, to the initial Qnexa NDA on October 28, 2010.  We resubmitted the Qnexa NDA in October 2011, with an FDA action date of April 17, 2012.  Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea.  In the area
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
2. VIVUS Reports Topline Findings From FORTRESS
3. VIVUS to Present at the Credit Suisse 2011 Healthcare Conference
4. VIVUS Resubmits Qnexa NDA to the FDA
5. VIVUS Provides Regulatory Update on QNEXA
6. VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
7. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
8. VIVUS Reports Second Quarter and First Six Months 2011 Financial Results
9. VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results
10. VIVUS to Present at Three Upcoming Investor Conferences in March
11. VIVUS Provides Regulatory Update on QNEXA NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014 ... European Medicines Agency (EMA) has granted Orphan ... lead product candidate, for the treatment of ... rare, severely disabling genetic disease characterized by ... (flare-ups) and new abnormal bone formation. This ...
(Date:11/21/2014)... Nov. 20, 2014  RedRick Technologies, a provider ... reading room environment guidance, has helped the new ... reading room, which may also serve as a ... Medicine. "In line with the ... of Radiology,s Imaging 3.0 ™ initiative, the ...
(Date:11/21/2014)... Nov. 20, 2014   Coqui RadioPharmaceuticals Corp. , ... U.S. commercial producer of Molybdenum-99 (Mo-99), is proud to ... INVAP to design its Medical Isotope Production Facility ... is the parent isotope of Technetium-99, which is used ... 2012, Congress passed legislation making it a national priority ...
Breaking Medicine Technology:Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2
(Date:11/22/2014)... November 22, 2014 A petition seeking ... http://www.morcellatorlawsuit2015.com ) in minimally-invasive hysterectomies and fibroid removal ... the end of October, Bernstein Liebhard LLP reports. ... as of November 21st, 2014. That represents an increase ... had signed on to the campaign.* , The campaign ...
(Date:11/22/2014)... New York, New York (PRWEB) November 22, 2014 ... been filed on behalf of patients who allegedly developed ... move forward in the federal multidistrict litigation now underway ... Liebhard LLP reports. According to court documents, the litigation ... at 10:00 a.m. The Court has directed Lead Counsel ...
(Date:11/22/2014)... 22, 2014 Forbes Living TV ... pleased to announce that Ashley Lombardo and friend Candy ... , Ms. Lombardo entered friend Candy Sherman to ... wrote of how her friend is courageously battling lung ... single mom. Despite medical bills piling up and the ...
(Date:11/22/2014)... November 22, 2014 Developers and plugin specialist ... plugin entitled FCPX 3D Model bringing the impossible to ... allows users to add obj files to FCPX enabling 3d ... “Blurring the line between professional and armature, FCPX 3D Model ... Film Studios allows Final Cut Pro X users to upload ...
(Date:11/22/2014)... (HealthDay News) -- A clinical trial of hydroxyurea therapy ... a year early because the results show it is ... and reduce the risk of stroke. The announcement ... centers in the United States and Canada, was made ... Blood Institute (NHLBI). Researchers compared monthly blood transfusions ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2
... administered Sunday to around 2.6 million children below the age ... in Delhi which has reported five polio cases this year. ... Dikshit Saturday expressed concern over the fresh cases but promised ... ,She said the migrant population that arrives in Delhi ...
... reproductive organs from the body of a man who is serving ... also found a uterus and ovaries and removed them. Both these ... R.K. Sharma, the doctor who conducted the operation late Saturday. ... 43 such cases have been found in the world," said Anil ...
... who has been under house arrest since May 2003 in ... regular visits from her personal doctor, United Nations sources said ... Undersecretary General for Political Affairs Ibrahim Gambari, who was granted ... night by Myanmar's ruling junta. ,Gambari, who also ...
... a million packets of fake medicines, most of them from ... according to officials here. ,The fake medicines include ... condoms. A sample that was investigated revealed that what was ... of brick dust. ,"A secret wave of dangerous ...
... in India's northeast living with HIV, the virus that causes ... access to treatment. ,"People are dying regularly and ... because such medicines are very expensive," said Dipak Singh, president ... ,Two MNPP members died earlier this week allegedly due to ...
... who are known for their entrepreneurial skills and its hold ... buying tribal girls// for their inheritance. This issue has caused ... of the main reasons for the fall in female child ... ,Prof Gaurang Jani, senior sociologist associated with the Gujarat ...
Cached Medicine News:Health News:Aung San Suu Kyi complains of irregular medical visits 2Health News:Hundreds dying in northeast from AIDS 2
... from Thermo Labsystems was designed specifically to ... features such as the new fast dial ... microvolumes help to define this as a ... new interchangeable handle plate offers a custom ...
Developed specifically for the 5000/5500 ultrasound consoles....
A Biplane Pediatric TEE transducer....
Super High Density, multi-frequency, convex array, small footprint transducer for scanning during craniotomies....
Medicine Products: